Churchill Capital Corp IX Ordinary Shares
NASDAQ:CCIXShell Companies
+$0.00 today
- Market cap
- $398.89M
- Beta
- -0.05
- P/E (TTM)
- 42.4
- EPS (TTM)
- $0.26
Volume 0.08M
Average 0.14M
CCIX Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Churchill Capital Corp IX Ordinary SharesNASDAQ: CCIX
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables remains negative
Q1 FY2026 net receivables was $0, compared with $0 a year earlier.
Context
- Net receivables amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Net receivables increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Net Receivables vs competitors
How CCIX compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Net receivables amounts to 0.0% of total assets for CCIX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $8.5B USD | +32980.0% | -31.0% | 0.7% | |
| Mar 2026 | $1.83B USD | +11.5% | +414.4% | 88.5% | |
| Apr 2026 | CA$26M CAD | -12.7% | +18.6% | 0.4% | |
| Mar 2026 | $14.89M USD | -0.0% | +20.8% | 0.4% | |
GPATGP-Act III Acquisition Corp. | Mar 2026 | $5.25K USD | — | — | 0.0% |
CCIXChurchill Capital Corp IX Ordinary Shares | Mar 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | +197.0% | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CCIX) | — | +5.8% | +20.8% | 0.0% | |
Competitors are the stored peer set for CCIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Cash & Equivalents | 0 | 2.41M | 2.47K |
| Short-term Investments | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 |
| Total Current Assets | 0 | 2.85M | 161.7K |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Long-term Investments | 0 | 296.12M | 307.62M |
| Tax Assets | 0 | 0 | 0 |
| Other Non-current Assets | 65.35K | 152.05K | 0 |
| Total Non-current Assets | 65.35K | 296.27M | 307.62M |
| Total Assets | 65.35K | 299.12M | 307.78M |
| Account Payables | 0 | 0 | 0 |
| Short-term Debt | 37.5K | 0 | 0 |
| Tax Payables | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 172.97K |
| Total Current Liabilities | 59.31K | 75K | 172.97K |
| Long-term Debt | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 10.06M | 10.06M |
| Total Non-current Liabilities | 0 | 10.06M | 10.06M |
| Total Liabilities | 59.31K | 10.14M | 10.24M |
| Common Stock | 719 | 296.12M | 307.62M |
| Retained Earnings | (18.96K) | (7.14M) | (10.07M) |
| Accumulated OCI | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Total Equity | 6.04K | 288.99M | 297.54M |
| Total Debt | 37.5K | 0 | 0 |
| Net Debt | 37.5K | (2.41M) | (2.47K) |
Churchill Capital Corp IX Ordinary Shares
NASDAQ:CCIX
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.